TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

被引：0
|
作者：
Ying Xing
Yuechao Liu
Tianbo Liu
Qingwei Meng
Hailing Lu
Wei Liu
Jing Hu
Chunhong Li
Mengru Cao
Shi Yan
Jian Huang
Ting Wang
Li Cai
机构：
[1] Harbin Medical University Cancer Hospital,The Fourth Department of Medical Oncology
[2] Harbin Medical University Cancer Hospital,Department of Gynecology
[3] Harbin Medical University,The Sixth Department of Medical Oncology
[4] Harbin Medical University Cancer Hospital,undefined
来源：
Cell Communication and Signaling | / 16卷
关键词：
TNFAIP8; NSCLC; Proliferation; Cisplatin chemoresistance; MDM2/p53 pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway
    Xing, Ying
    Liu, Yuechao
    Liu, Tianbo
    Meng, Qingwei
    Lu, Hailing
    Liu, Wei
    Hu, Jing
    Li, Chunhong
    Cao, Mengru
    Yan, Shi
    Huang, Jian
    Wang, Ting
    Cai, Li
    CELL COMMUNICATION AND SIGNALING, 2018, 16
  • [2] Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway
    Xu, Jianhao
    Ni, Liwei
    Zhao, Fenglun
    Dai, Xiaoxiao
    Tao, Jialong
    Pan, Jia
    Shi, Aiming
    Shen, Zhu
    Su, Cunjin
    Zhang, Yusong
    AGING-US, 2021, 13 (04): : 5986 - 6009
  • [3] α-Hederin promotes ferroptosis and reverses cisplatin chemoresistance in non-small cell lung cancer
    Han, Shugao
    Yang, Xi
    Zhuang, Jing
    Zhou, Qing
    Wang, Jingjing
    Ru, Lixin
    Niu, Furong
    Mao, Wei
    AGING-US, 2024, 16 (02): : 1298 - 1317
  • [4] LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
    Li, Yang
    Ma, Hong-Yu
    Hu, Xiao-Wei
    Qu, Yuan-Yuan
    Wen, Xin
    Zhang, Yu
    Xu, Qing-Yong
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [5] Ginsenoside CK Promotes Cell Apoptosis via Regulating P53 Signal Pathway in Non-Small Cell Lung Cancer
    Liu, Xinze
    Feng, Lin
    Jin, Xin
    Sun, Kaijing
    Sun, Ying
    Wu, Xinmin
    Xia, Mingjie
    Tan, Renbo
    Yang, Hongmei
    Li, Guangzhe
    Wu, Wei
    Zu, Shuang
    Li, Anning
    Chen, Changbao
    Wan, Xilin
    DRUG DEVELOPMENT RESEARCH, 2025, 86 (02)
  • [6] Sanggenol L induces ferroptosis in non-small cell lung cancer cells via regulating the miR-26a-1-3p/MDM2/p53 signaling pathway
    Fu, Rong
    You, Yujie
    Wang, Yuqing
    Wang, Jue
    Lu, Yu
    Gao, Rui
    Pang, Min
    Yang, Peng
    Wang, Hailong
    BIOCHEMICAL PHARMACOLOGY, 2024, 226
  • [7] The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
    Deben, Christophe
    Wouters, An
    Op de Beeck, Ken
    van den Bossche, Jolien
    Jacobs, Julie
    Zwaenepoel, Karen
    Peeters, Marc
    Van Meerbeeck, Jan
    Lardon, Filip
    Rolfo, Christian
    Deschoolmeester, Vanessa
    Pauwels, Patrick
    ONCOTARGET, 2015, 6 (26) : 22666 - 22679
  • [8] Tryptanthrin reduces mast cell proliferation promoted by TSLP through modulation of MDM2 and p53
    Han, Na-Ra
    Kim, Hyung-Min
    Jeong, Hyun-Ja
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 71 - 77
  • [9] miR-1305 Inhibits The Progression Of Non-Small Cell Lung Cancer By Regulating MDM2
    Cai, Yuxing
    Hao, Yi
    Ren, HaiFeng
    Dang, ZhiGuo
    Xu, Hui
    Xue, Xiangfei
    Gao, Yan
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9529 - 9540
  • [10] Overexpression of MYCN promotes proliferation of non-small cell lung cancer
    Liu, Kun
    Wang, Shuo
    Liu, Yifei
    Gu, Jun
    Gu, Shudong
    Xu, Zhen
    Zhang, Rui
    Wang, Zhiwen
    Ma, Huaci
    Chen, Yingying
    Ji, Lili
    TUMOR BIOLOGY, 2016, 37 (09) : 12855 - 12866
12345